Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Winton Matthew | Chief Commercial and Business | 6 | $117.1K | $0 | 2026-10-22 |
| De Rosch Mark | EVP, RA and GA and PgM | 2 | $0 | $0 | 2026-10-22 |
| Blackburn Kelly | VP, Clinical Development | 5 | $0 | $0 | 2026-10-22 |
| BOGER JOSHUA S | Director, 10% Owner | 10 | $3.00M | $0 | 2026-06-11 |
| Quigley David | Director | 2 | $0 | $0 | 2026-06-08 |
| Sabbagh Marwan | Director | 4 | $0 | $0 | 2026-06-08 |
| Poulton Jeffrey V. | Director | 4 | $0 | $0 | 2026-06-08 |
| ZAVRL FRANK | Director | 4 | $0 | $0 | 2026-06-08 |
| Gregoire Sylvie | Director, 10% Owner | 15 | $282.7K | $0 | 2026-06-08 |
| Hollingsworth Jane H | Director | 7 | $0 | $0 | 2026-06-08 |
| ALAM JOHN J | CEO & President | 15 | $282.7K | $0 | 2026-06-08 |
| ELDER WILLIAM ROBERT | GC & Secretary | 9 | $109.3K | $0 | 2026-02-11 |
| Cobuzzi Robert Joseph Jr. | Chief Operating Officer | 3 | $0 | $0 | 2025-02-04 |
| TANNER JOHN WILLIAM | Chief Financial Officer | 3 | $0 | $0 | 2024-01-26 |
| DAVIDSON JILL | Director | 1 | $0 | $0 | 2023-09-15 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| De Rosch Mark | EVP, RA and GA and PgM | A Award deriv | 2026-10-22 | 2026-10-23 | 19,100 | — | $0 | 19,100 | SEC↗ |
| Winton Matthew | Chief Commercial and Busines | A Award deriv | 2026-10-22 | 2026-10-23 | 19,100 | — | $0 | 19,100 | SEC↗ |
| Blackburn Kelly | EVP, Clinical Development | A Award deriv | 2026-10-22 | 2026-10-23 | 19,100 | — | $0 | 19,100 | SEC↗ |
| BOGER JOSHUA S | Director, 10% Owner | P Buy deriv | 2026-06-11 | 2026-06-15 | 955,414 | — | $0 | 955,414 | SEC↗ |
| BOGER JOSHUA S | Director, 10% Owner | P Buy deriv | 2026-06-11 | 2026-06-15 | 955,414 | — | $0 | 955,414 | SEC↗ |
| BOGER JOSHUA S | Director, 10% Owner | P Buy | 2026-06-11 | 2026-06-15 | 955,414 | $3.14 | $3.00M | 1,795,865 | SEC↗ |
| ALAM JOHN J | CEO & President | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| BOGER JOSHUA S | Director, 10% Owner | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| Hollingsworth Jane H | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| Poulton Jeffrey V. | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| Quigley David | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| Sabbagh Marwan | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| ZAVRL FRANK | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| ALAM JOHN J | CEO & President | A Award deriv | 2026-02-11 | 2026-02-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Blackburn Kelly | EVP, Clinical Development | A Award deriv | 2026-02-11 | 2026-02-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| De Rosch Mark | EVP, RA and GA and PgM | A Award deriv | 2026-02-11 | 2026-02-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | A Award deriv | 2026-02-11 | 2026-02-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | A Award deriv | 2026-02-11 | 2026-02-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Winton Matthew | Chief Commercial and Busines | A Award deriv | 2026-02-11 | 2026-02-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | P Buy | 2025-11-18 | 2025-11-19 | 2,500 | $8.32 | $20.8K | 12,500 | SEC↗ |
| Winton Matthew | Chief Commercial and Busines | P Buy | 2025-11-18 | 2025-11-19 | 1,500 | $7.95 | $11.9K | 15,000 | SEC↗ |
| ALAM JOHN J | CEO & President | P Buy | 2025-11-17 | 2025-11-19 | 10,793 | $8.46 | $91.3K | 12,500 | SEC↗ |
| ALAM JOHN J | CEO & President | P Buy | 2025-11-17 | 2025-11-19 | 10,807 | $8.46 | $91.4K | 1,484,078 | SEC↗ |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | P Buy | 2025-11-17 | 2025-11-19 | 1,000 | $8.45 | $8.4K | 10,000 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | P Buy | 2025-11-17 | 2025-11-19 | 10,807 | $8.46 | $91.4K | 12,500 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | P Buy | 2025-11-17 | 2025-11-19 | 10,793 | $8.46 | $91.3K | 1,484,078 | SEC↗ |
| Winton Matthew | Chief Commercial and Busines | P Buy | 2025-11-17 | 2025-11-19 | 3,500 | $8.43 | $29.5K | 13,500 | SEC↗ |
| Winton Matthew | Chief Commercial and Busines | P Buy | 2025-11-14 | 2025-11-17 | 10,000 | $7.57 | $75.7K | 10,000 | SEC↗ |
| ALAM JOHN J | CEO & President | P Buy | 2025-11-14 | 2025-11-17 | 1,693 | $7.55 | $12.8K | 1,473,271 | SEC↗ |
| ALAM JOHN J | CEO & President | P Buy | 2025-11-14 | 2025-11-17 | 1,707 | $7.57 | $12.9K | 1,707 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | P Buy | 2025-11-14 | 2025-11-17 | 1,707 | $7.57 | $12.9K | 1,473,285 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | P Buy | 2025-11-14 | 2025-11-17 | 1,693 | $7.55 | $12.8K | 1,693 | SEC↗ |
| ALAM JOHN J | CEO & President | P Buy | 2025-11-13 | 2025-11-17 | 4,447 | $7.51 | $33.4K | 1,471,578 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | P Buy | 2025-11-13 | 2025-11-17 | 4,447 | $7.51 | $33.4K | 1,471,578 | SEC↗ |
| ALAM JOHN J | CEO & President | P Buy | 2025-11-12 | 2025-11-13 | 5,553 | $7.35 | $40.8K | 1,467,131 | SEC↗ |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | P Buy | 2025-11-12 | 2025-11-13 | 3,500 | $7.44 | $26.0K | 9,000 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | P Buy | 2025-11-12 | 2025-11-13 | 5,553 | $7.35 | $40.8K | 1,467,131 | SEC↗ |
| Quigley David | Director | A Award deriv | 2025-10-27 | 2025-12-05 | 16,200 | — | $0 | 16,200 | SEC↗ |
| Winton Matthew | Chief Commercial and Busines | A Award deriv | 2025-10-06 | 2025-10-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| Hollingsworth Jane H | Director | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| Poulton Jeffrey V. | Director | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| Sabbagh Marwan | Director | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| BOGER JOSHUA S | Director, 10% Owner | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| ZAVRL FRANK | Director | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| ALAM JOHN J | CEO & President | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | P Buy | 2025-05-14 | 2025-05-14 | 4,233 | $8.46 | $35.8K | 5,500 | SEC↗ |
| ALAM JOHN J | CEO & President | A Award deriv | 2025-02-04 | 2025-02-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Blackburn Kelly | SVP, Clinical Development | A Award deriv | 2025-02-04 | 2025-02-14 | 27,000 | — | $0 | 27,000 | SEC↗ |
| Cobuzzi Robert Joseph Jr. | Chief Operating Officer | A Award deriv | 2025-02-04 | 2025-02-14 | 27,000 | — | $0 | 27,000 | SEC↗ |
| ELDER WILLIAM ROBERT | CFO & GC | A Award deriv | 2025-02-04 | 2025-02-14 | 27,000 | — | $0 | 27,000 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | A Award deriv | 2025-02-04 | 2025-02-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ELDER WILLIAM ROBERT | CFO & GC | P Buy | 2024-08-27 | 2024-08-27 | 1,000 | $18.16 | $18.2K | 1,267 | SEC↗ |
| ZAVRL FRANK | Director | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| Sabbagh Marwan | Director | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| Poulton Jeffrey V. | Director | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| Hollingsworth Jane H | Director | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| BOGER JOSHUA S | Director, 10% Owner | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| ALAM JOHN J | CEO & President | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| BOGER JOSHUA S | Director, 10% Owner | X Exercise deriv | 2024-02-26 | 2024-02-28 | 495,995 | — | $0 | 0 | SEC↗ |
| BOGER JOSHUA S | Director, 10% Owner | S Sale | 2024-02-26 | 2024-02-28 | 36 | — | $0 | 840,451 | SEC↗ |
| BOGER JOSHUA S | Director, 10% Owner | X Exercise | 2024-02-26 | 2024-02-28 | 495,995 | — | $0 | 840,487 | SEC↗ |
| BOGER JOSHUA S | Director | A Award deriv | 2024-02-12 | 2024-02-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Cobuzzi Robert Joseph Jr. | Chief Operating Officer | A Award deriv | 2024-01-26 | 2024-01-26 | 55,721 | — | $0 | 55,721 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | A Award deriv | 2024-01-26 | 2024-01-26 | 35,500 | — | $0 | 35,500 | SEC↗ |
| ELDER WILLIAM ROBERT | GC & Secretary | A Award deriv | 2024-01-26 | 2024-01-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| TANNER JOHN WILLIAM | Chief Financial Officer | A Award deriv | 2024-01-26 | 2024-01-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Blackburn Kelly | SVP, Clinical Development | A Award deriv | 2024-01-26 | 2024-01-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ALAM JOHN J | CEO & President | A Award deriv | 2024-01-26 | 2024-01-26 | 35,500 | — | $0 | 35,500 | SEC↗ |
| TANNER JOHN WILLIAM | Chief Financial Officer | A Award deriv | 2023-11-20 | 2023-11-22 | 32,000 | — | $0 | 32,000 | SEC↗ |
| ALAM JOHN J | CEO & President | G Gift | 2023-11-09 | 2023-11-09 | 12,500 | — | $0 | 729,539 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | G Gift | 2023-11-09 | 2023-11-09 | 10,000 | — | $0 | 732,039 | SEC↗ |
| Blackburn Kelly | VP, Clinical Development | A Award deriv | 2023-09-15 | 2023-09-15 | 16,000 | — | $0 | 16,000 | SEC↗ |
| DAVIDSON JILL | Director | A Award deriv | 2023-09-15 | 2023-09-15 | 6,450 | — | $0 | 6,450 | SEC↗ |
| ELDER WILLIAM ROBERT | GC & Secretary | A Award deriv | 2023-09-15 | 2023-09-15 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | A Award deriv | 2023-09-15 | 2023-09-15 | 6,450 | — | $0 | 6,450 | SEC↗ |
| Gregoire Sylvie | Director, 10% Owner | A Award deriv | 2023-09-15 | 2023-09-15 | 35,500 | — | $0 | 35,500 | SEC↗ |
| Hollingsworth Jane H | Director | A Award deriv | 2023-09-15 | 2023-09-15 | 6,450 | — | $0 | 6,450 | SEC↗ |
| Poulton Jeffrey V. | Director | A Award deriv | 2023-09-15 | 2023-09-15 | 6,450 | — | $0 | 6,450 | SEC↗ |
| Sabbagh Marwan | Director | A Award deriv | 2023-09-15 | 2023-09-15 | 6,450 | — | $0 | 6,450 | SEC↗ |
| ZAVRL FRANK | Director | A Award deriv | 2023-09-15 | 2023-09-15 | 6,450 | — | $0 | 6,450 | SEC↗ |
| ALAM JOHN J | CEO & President | A Award deriv | 2023-09-15 | 2023-09-15 | 35,500 | — | $0 | 35,500 | SEC↗ |
| ALAM JOHN J | CEO & President | A Award deriv | 2023-09-15 | 2023-09-15 | 6,450 | — | $0 | 6,450 | SEC↗ |
| TANNER JOHN WILLIAM | Chief Financial Officer | A Award deriv | 2023-09-15 | 2023-09-15 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Cobuzzi Robert Joseph Jr. | Chief Operating Officer | A Award deriv | 2023-09-15 | 2023-09-15 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Hollingsworth Jane H | Director | M Exercise deriv | 2023-08-31 | 2023-09-06 | 122 | — | $0 | 0 | SEC↗ |
| Hollingsworth Jane H | Director | M Exercise | 2023-08-31 | 2023-09-06 | 122 | — | $0 | 943 | SEC↗ |
| Hollingsworth Jane H | Director | D To issuer | 2023-08-31 | 2023-09-06 | 45 | — | $0 | 898 | SEC↗ |